3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
SMRTR summary
MIT's James Collins uses AI to design new antibiotics against drug-resistant bacteria. His team created millions of candidate molecules, with seven showing promise against resistant gonorrhea and MRSA.
SMRTR provides this summary for quick context. The original article belongs to Daily.dev.
Read the original article